home / open_comments

documents

Federal regulatory documents currently open for public comment.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

70 rows where agency_id = "FDA" and document_type = "Notice" sorted by comment_end_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 1

  • Notice · 70 ✖

agency_id 1

  • FDA · 70 ✖
id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date ▲ last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-N-0131-0001 FDA FDA-2026-N-0131 FDA Rare Disease Innovation Hub Future Programming; Request for Comments Notice Request for Comments 2026-01-30 2026 1 2026-01-30 2027-01-01 2026-03-22 09:00:09 2026-01903 1 0 09000064b91893ee
FDA-2016-D-1280-0005 FDA FDA-2016-D-1280 Electronic Submission of Postmarketing Individual Case Safety Reports to the Food and Drug Administration Adverse Event Monitoring System Using International Council of Harmonisation E2B(R3) Data Standards; Regional Data Elements and Implementation Schedule Notice Announcement 2026-04-06 2026 4 2026-04-06 2026-10-02 2026-04-07 09:00:25 2026-06660 1 0 09000064b9253dbc
FDA-2025-E-2426-0006 FDA FDA-2025-E-2426 Determination of Regulatory Review Period for Purposes of Patent Extension; BLUJEPA Notice Determinations 2026-02-13 2026 2 2026-02-13 2026-08-13 2026-02-13 20:03:13 2026-02901 1 0 09000064b91aa6fb
FDA-2025-E-0152-0006 FDA FDA-2025-E-0152 Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY Notice Determinations 2026-02-06 2026 2 2026-02-06 2026-08-06 2026-02-06 20:05:43 2026-02388 1 0 09000064b919467e
FDA-2025-E-0153-0006 FDA FDA-2025-E-0153 Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY Notice Determinations 2026-02-06 2026 2 2026-02-06 2026-08-06 2026-02-06 20:06:34 2026-02388 1 0 09000064b919467f
FDA-2024-E-3539-0006 FDA FDA-2024-E-3539 Determination of Regulatory Review Period for Purposes of Patent Extension; BEQVEZ Notice Determinations 2026-02-06 2026 2 2026-02-06 2026-08-06 2026-02-14 13:19:52 2026-02387 1 0 09000064b9195b4d
FDA-2025-E-0154-0006 FDA FDA-2025-E-0154 Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY Notice Determinations 2026-02-06 2026 2 2026-02-06 2026-08-06 2026-02-06 20:07:01 2026-02388 1 0 09000064b9195c17
FDA-2026-N-3273-0001 FDA FDA-2026-N-3273 Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments; Public Meeting; Request for Comments Notice Request for Comments 2026-04-15 2026 4 2026-04-15 2026-07-24 2026-04-15 17:05:22 2026-07248 1 0 09000064b9282224
FDA-2023-N-0119-0020 FDA FDA-2023-N-0119 Fiscal Year 2026 Generic Drug Science and Research Initiatives Workshop; Public Workshop; Request for Comments Notice Request for Comments 2026-02-27 2026 2 2026-02-27 2026-07-11 2026-04-14 09:00:18 2026-03961 1 0 09000064b91e326c
FDA-2026-N-2366-0001 FDA FDA-2026-N-2366 Commissioner’s National Priority Voucher (CNPV) Pilot Program; Public Hearing; Request for Comments Notice Request for Comments 2026-03-23 2026 3 2026-03-23 2026-06-30 2026-04-12 09:00:14 2026-05573 1 0 09000064b922c21a
FDA-2026-N-2742-0001 FDA FDA-2026-N-2742 Agency Information Collection Activities; Proposed Collection; Comment Request; Color Additive Certification Notice 60 Day Proposed Information Collection 2026-04-10 2026 4 2026-04-10 2026-06-10 2026-04-10 18:01:37 2026-06936 1 0 09000064b926825a
FDA-2026-N-2743-0001 FDA FDA-2026-N-2743 Agency Information Collection Activities; Proposed Collection; Comment Request; Submission of Petitions: Food Additive, Color Additive (Including Labeling), Submission of Information to a Master File in Support of Petitions; and Electronic Submission Using Food and Drug Administration Form 3503 Notice 60 Day Proposed Information Collection 2026-04-10 2026 4 2026-04-10 2026-06-10 2026-04-10 18:22:24 2026-06935 1 0 09000064b926821b
FDA-2026-N-2915-0001 FDA FDA-2026-N-2915 Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Approval of Medical Devices Notice 60 Day Proposed Information Collection 2026-04-10 2026 4 2026-04-10 2026-06-10 2026-04-10 17:47:50 2026-06906 1 0 09000064b9268328
FDA-2026-N-2431-0001 FDA FDA-2026-N-2431 Agency Information Collection Activities; Proposed Collection; Comment Request; Administrative Practices and Procedures; Formal Hearings Notice 60 Day Proposed Information Collection 2026-04-07 2026 4 2026-04-07 2026-06-09 2026-04-14 19:40:33 2026-06719 1 0 09000064b9255485
FDA-2025-E-0863-0006 FDA FDA-2025-E-0863 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:37:03 2026-06478 1 0 09000064b924cccb
FDA-2025-E-0845-0006 FDA FDA-2025-E-0845 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:34:01 2026-06478 1 0 09000064b924dac3
FDA-2025-E-0866-0006 FDA FDA-2025-E-0866 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:42:13 2026-06478 1 0 09000064b924ccce
FDA-2025-E-0372-0005 FDA FDA-2025-E-0372 Determination of Regulatory Review Period for Purposes of Patent Extension; ZIIHERA Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:52:42 2026-06476 1 0 09000064b924da88
FDA-2025-E-3074-0006 FDA FDA-2025-E-3074 Determination of Regulatory Review Period for Purposes of Patent Extension; EMRELIS Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:57:30 2026-06480 1 0 09000064b924c470
FDA-2025-E-0871-0006 FDA FDA-2025-E-0871 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:49:10 2026-06478 1 0 09000064b924c46e
FDA-2025-E-3073-0006 FDA FDA-2025-E-3073 Determination of Regulatory Review Period for Purposes of Patent Extension; EMRELIS Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:55:54 2026-06480 1 0 09000064b924da86
FDA-2025-E-3626-0006 FDA FDA-2025-E-3626 Determination of Regulatory Review Period for Purposes of Patent Extension; ENFLONSIA Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:59:57 2026-06479 1 0 09000064b924d98d
FDA-2025-E-0870-0006 FDA FDA-2025-E-0870 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:48:07 2026-06478 1 0 09000064b924c46d
FDA-2026-N-2740-0001 FDA FDA-2026-N-2740 Agency Information Collection Activities; Proposed Collection; Comment Request; Customer/Partner Customer Service Satisfaction Surveys Notice 60 Day Proposed Information Collection 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:29:44 2026-06482 1 0 09000064b924dac4
FDA-2025-E-0868-0006 FDA FDA-2025-E-0868 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:44:23 2026-06478 1 0 09000064b924c0e1
FDA-2025-E-0865-0006 FDA FDA-2025-E-0865 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:39:45 2026-06478 1 0 09000064b924cccd
FDA-2025-E-1672-0007 FDA FDA-2025-E-1672 Determination of Regulatory Review Period for Purposes of Patent Extension; ENCELTO Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 18:06:28 2026-06477 1 0 09000064b924d940
FDA-2014-E-2328-0006 FDA FDA-2014-E-2328 Determination of Regulatory Review Period for Purposes of Patent Extension; INJECTAFER Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 18:09:13 2026-06483 1 0 09000064b924d4f5
FDA-2025-E-0864-0006 FDA FDA-2025-E-0864 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:38:27 2026-06478 1 0 09000064b924cccc
FDA-2025-E-0872-0006 FDA FDA-2025-E-0872 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:50:02 2026-06478 1 0 09000064b924c46f
FDA-2025-E-0867-0006 FDA FDA-2025-E-0867 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:43:31 2026-06478 1 0 09000064b924c0e0
FDA-2025-E-0158-0006 FDA FDA-2025-E-0158 Determination of Regulatory Review Period for Purposes of Patent Extension; HYMPAVZI Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 18:04:00 2026-06481 1 0 09000064b924d942
FDA-2025-E-0869-0006 FDA FDA-2025-E-0869 Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY Notice Determinations 2026-04-03 2026 4 2026-04-03 2026-06-03 2026-04-03 17:45:32 2026-06478 1 0 09000064b924ba07
FDA-2026-N-0809-0001 FDA FDA-2026-N-0809 Recommendations on Scale-Up and Postapproval Changes Guidances for Industry; Request for Comments Notice Request for Comments 2026-03-03 2026 3 2026-03-03 2026-06-02 2026-04-13 09:00:28 2026-04196 1 0 09000064b91ed501
FDA-2026-N-2476-0001 FDA FDA-2026-N-2476 Advancing the Use of Digital Health Technologies in Clinical Investigations for Drugs and Biological Products; Request for Information and Comments Notice Request for Comments 2026-03-31 2026 3 2026-03-31 2026-06-02 2026-04-10 09:00:28 2026-06184 1 0 09000064b92439d6
FDA-2024-E-5140-0006 FDA FDA-2024-E-5140 Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM Notice Determinations 2025-11-24 2025 11 2025-11-24 2026-05-27 2026-01-24 13:16:48 2025-20667 1 0 09000064b908e3f0
FDA-2024-E-5139-0006 FDA FDA-2024-E-5139 Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM Notice Determinations 2025-11-24 2025 11 2025-11-24 2026-05-27 2026-01-24 13:16:48 2025-20667 1 0 09000064b908e3ef
FDA-2024-E-5141-0006 FDA FDA-2024-E-5141 Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM Notice Determinations 2025-11-24 2025 11 2025-11-24 2026-05-27 2026-01-24 13:16:50 2025-20667 1 0 09000064b9092f99
FDA-2024-E-5681-0006 FDA FDA-2024-E-5681 Determination of Regulatory Review Period for Purposes of Patent Extension; ALTIUS DIRECT ELECTRICAL NERVE STIMULATION SYSTEM Notice Determinations 2025-11-24 2025 11 2025-11-24 2026-05-27 2025-11-24 19:32:14 2025-20668 1 0 09000064b9093521
FDA-2026-N-2365-0001 FDA FDA-2026-N-2365 Agency Information Collection Activities; Proposed Collection; Comment Request; Reporting Associated With Animal Drug and Animal Generic Drug User Fees Notice 60 Day Proposed Information Collection 2026-03-23 2026 3 2026-03-23 2026-05-23 2026-03-23 17:37:47 2026-05620 1 0 09000064b922c25e
FDA-2026-N-2364-0001 FDA FDA-2026-N-2364 Agency Information Collection Activities; Proposed Collection; Comment Request; Food and Drug Administration Advisory Committees Notice 60 Day Proposed Information Collection 2026-03-23 2026 3 2026-03-23 2026-05-23 2026-03-25 09:00:29 2026-05623 1 0 09000064b922c187
FDA-2026-N-1849-0001 FDA FDA-2026-N-1849 Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Notifications Submission Notice 60 Day Proposed Information Collection 2026-03-19 2026 3 2026-03-19 2026-05-19 2026-03-19 17:24:48 2026-05329 1 0 09000064b9224334
FDA-2026-N-2279-0001 FDA FDA-2026-N-2279 Preparation for International Cooperation on Cosmetics Regulation Twentieth Annual Meeting (ICCR–20); Request for Comments Notice Request for Comments 2026-03-18 2026 3 2026-03-18 2026-05-19 2026-04-03 09:00:22 2026-05280 1 0 09000064b922165c
FDA-2026-N-1736-0001 FDA FDA-2026-N-1736 Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational New Drug Application Requirements Notice 60 Day Proposed Information Collection 2026-03-13 2026 3 2026-03-13 2026-05-13 2026-03-13 17:05:05 2026-04938 1 0 09000064b92145ad
FDA-2025-N-4731-0052 FDA FDA-2025-N-4731 Increasing Access to Nonprescription Drugs; Public Meeting; Request for Comments Notice Request for Comments 2026-04-15 2026 4 2026-04-15 2026-05-09 2026-04-15 17:08:45 2026-07335 1 0 09000064b9282192
FDA-2025-E-0493-0006 FDA FDA-2025-E-0493 Determination of Regulatory Review Period for Purposes of Patent Extension; ENSACOVE Notice Determinations 2026-03-06 2026 3 2026-03-06 2026-05-06 2026-03-06 19:06:30 2026-04491 1 0 09000064b91f8458
FDA-2026-N-2741-0001 FDA FDA-2026-N-2741 Consideration of Acceptable Market Name Change for Certain Rockfish (Sebastes spp.); Request for Information Notice Requests for Information (RFI) 2026-04-01 2026 4 2026-04-01 2026-05-02 2026-04-14 19:40:35 2026-06294 1 0 09000064b924995a
FDA-2026-N-1867-0001 FDA FDA-2026-N-1867 Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—New Drug Application 220359, for Camizestrant Tablets; Supplemental New Drug Application (sNDA) 218197/S–004, for Truqap (Capivasertib) Tablets Notice Request for Comments 2026-03-09 2026 3 2026-03-09 2026-04-30 2026-04-16 09:00:12 2026-04497 1 0 09000064b9200842
FDA-2026-N-0686-0001 FDA FDA-2026-N-0686 Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements Notice 60 Day Proposed Information Collection 2026-02-24 2026 2 2026-02-24 2026-04-28 2026-02-24 19:45:30 2026-03589 1 0 09000064b91d5809
FDA-2024-E-3572-0007 FDA FDA-2024-E-3572 Determination of Regulatory Review Period for Purposes of Patent Extension; TEVIMBRA Notice Determinations 2026-02-26 2026 2 2026-02-26 2026-04-28 2026-02-26 20:52:55 2026-03851 1 0 09000064b91deb48
FDA-2025-E-0161-0006 FDA FDA-2025-E-0161 Determination of Regulatory Review Period for Purposes of Patent Extension; ORLYNVAH Notice Determinations 2026-02-26 2026 2 2026-02-26 2026-04-28 2026-02-26 20:55:38 2026-03848 1 0 09000064b91deb09
FDA-2024-E-3565-0006 FDA FDA-2024-E-3565 Determination of Regulatory Review Period for Purposes of Patent Extension; LIMFLOW SYSTEM Notice Determinations 2026-02-26 2026 2 2026-02-26 2026-04-28 2026-02-26 20:38:14 2026-03855 1 0 09000064b91e03ee
FDA-2024-E-3555-0007 FDA FDA-2024-E-3555 Determination of Regulatory Review Period for Purposes of Patent Extension; LIMFLOW SYSTEM Notice Determinations 2026-02-26 2026 2 2026-02-26 2026-04-28 2026-02-26 20:35:08 2026-03855 1 0 09000064b91dec48
FDA-2025-E-1226-0007 FDA FDA-2025-E-1226 Determination of Regulatory Review Period for Purposes of Patent Extension; AEROPACE Notice Determinations 2026-02-26 2026 2 2026-02-26 2026-04-28 2026-02-26 20:32:36 2026-03849 1 0 09000064b91dec81
FDA-2025-E-1229-0006 FDA FDA-2025-E-1229 Determination of Regulatory Review Period for Purposes of Patent Extension; MERIT MEDICAL WRAPSODY Notice Determinations 2026-02-26 2026 2 2026-02-26 2026-04-28 2026-02-26 20:43:12 2026-03853 1 0 09000064b91e03f1
FDA-2025-E-0371-0006 FDA FDA-2025-E-0371 Determination of Regulatory Review Period for Purposes of Patent Extension; REVUFORJ Notice Determinations 2026-02-26 2026 2 2026-02-26 2026-04-28 2026-02-26 20:46:51 2026-03847 1 0 09000064b91dec08
FDA-2024-E-3564-0006 FDA FDA-2024-E-3564 Determination of Regulatory Review Period for Purposes of Patent Extension; LIMFLOW SYSTEM Notice Determinations 2026-02-26 2026 2 2026-02-26 2026-04-28 2026-02-26 20:36:56 2026-03855 1 0 09000064b91e03ed
FDA-2025-E-0500-0006 FDA FDA-2025-E-0500 Determination of Regulatory Review Period for Purposes of Patent Extension; TRYNGOLZA Notice Determinations 2026-02-26 2026 2 2026-02-26 2026-04-28 2026-02-26 20:57:25 2026-03850 1 0 09000064b91deac5
FDA-2025-E-1228-0006 FDA FDA-2025-E-1228 Determination of Regulatory Review Period for Purposes of Patent Extension; MERIT MEDICAL WRAPSODY Notice Determinations 2026-02-26 2026 2 2026-02-26 2026-04-28 2026-02-27 10:00:26 2026-03853 1 0 09000064b91dec45
FDA-2026-N-0027-0001 FDA FDA-2026-N-0027 Agency Information Collection Activities; Proposed Collection; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing Notice 60 Day Proposed Information Collection 2026-02-25 2026 2 2026-02-25 2026-04-28 2026-02-25 19:16:33 2026-03773 1 0 09000064b91da53a
FDA-2026-N-0496-0001 FDA FDA-2026-N-0496 Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice Regulations for Medicated Feeds Notice 60 Day Proposed Information Collection 2026-02-25 2026 2 2026-02-25 2026-04-28 2026-04-03 09:00:19 2026-03772 1 0 09000064b91da591
FDA-2023-P-3942-1120 FDA FDA-2023-P-3942 Labeling and Preventing Cross-Contact of Gluten for Packaged Foods; Request for Information Notice Requests for Information (RFI) 2026-01-22 2026 1 2026-01-22 2026-04-23 2026-04-16 09:00:08 2026-01121 1 0 09000064b91781b1
FDA-2026-N-0746-0001 FDA FDA-2026-N-0746 Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals (Including Active Pharmaceutical Ingredients) and the Advanced Manufacturing Technologies Designation Program Notice 60 Day Proposed Information Collection 2026-02-20 2026 2 2026-02-20 2026-04-22 2026-03-14 09:00:11 2026-03326 1 0 09000064b91c75af
FDA-2026-N-1305-0001 FDA FDA-2026-N-1305 Agency Information Collection Activities; Proposed Collection; Comment Request; New Animal Drugs for Minor Use and Minor Species Notice 60 Day Proposed Information Collection 2026-02-20 2026 2 2026-02-20 2026-04-22 2026-04-06 09:00:14 2026-03353 1 0 09000064b91c750d
FDA-2026-N-0499-0001 FDA FDA-2026-N-0499 Agency Information Collection Activities; Proposed Collection; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice Notice 60 Day Proposed Information Collection 2026-02-20 2026 2 2026-02-20 2026-04-22 2026-02-20 20:23:05 2026-03332 1 0 09000064b91c75b1
FDA-2026-N-1303-0001 FDA FDA-2026-N-1303 Agency Information Collection Activities; Proposed Collection; Comment Request; Adverse Events Associated With New Animal Drugs Notice 60 Day Proposed Information Collection 2026-02-20 2026 2 2026-02-20 2026-04-22 2026-02-20 20:55:00 2026-03352 1 0 09000064b91c3035
FDA-2026-N-0684-0001 FDA FDA-2026-N-0684 Agency Information Collection Activities; Proposed Collection; Comment Request; Approved Organizations for Wholesale Drug Distributors and Third-Party Logistics Providers Notice 60 Day Proposed Information Collection 2026-02-20 2026 2 2026-02-20 2026-04-22 2026-02-20 20:51:55 2026-03333 1 0 09000064b91c307f
FDA-2026-N-0497-0001 FDA FDA-2026-N-0497 Agency Information Collection Activities; Proposed Collection; Comment Request; Patent Term Restoration; Due Diligence Petitions; Filing, Format, and Content of Petitions Notice 60 Day Proposed Information Collection 2026-02-18 2026 2 2026-02-18 2026-04-21 2026-02-18 19:12:13 2026-03094 1 0 09000064b91b8f13
FDA-2026-N-0498-0001 FDA FDA-2026-N-0498 Agency Information Collection Activities; Proposed Collection; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products Notice 60 Day Proposed Information Collection 2026-02-19 2026 2 2026-02-19 2026-04-21 2026-02-19 20:20:32 2026-03311 1 0 09000064b91bd409
FDA-2025-E-0862-0006 FDA FDA-2025-E-0862 Determination of Regulatory Review Period for Purposes of Patent Extension; SYMVESS Notice Determinations 2026-02-19 2026 2 2026-02-19 2026-04-21 2026-02-19 20:54:45 2026-03312 1 0 09000064b91bd33f

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
            id TEXT PRIMARY KEY,
            agency_id TEXT,
            docket_id TEXT,
            title TEXT,
            document_type TEXT,
            subtype TEXT,
            posted_date TEXT,
            posted_year INTEGER,
            posted_month INTEGER,
            comment_start_date TEXT,
            comment_end_date TEXT,
            last_modified TEXT,
            fr_doc_num TEXT,
            open_for_comment INTEGER,
            withdrawn INTEGER,
            object_id TEXT
        );
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date);
CREATE INDEX idx_docs_withdrawn ON documents(withdrawn);
Powered by Datasette · Queries took 198.245ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API